Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children

By Halperin S.A.   Smith B.   Mabrouk T.   Germain M.   Trepanier P.   Hassell T.   Treanor J.   Gauthier R.   Mills E.L.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1240-1247

Elsevier

Access to resources Recommend Favorite

The hemagglutination inhibition antibody responses to an inactivated influenza vaccine among healthy adults: with special reference to the prevaccination antibody and its interaction with age

By Hirota Y.   Kaji M.   Ide S.   Goto S.   Oka T.  

Vaccine, Vol. 14, Iss. 17, 1996-12 ,pp. : 1597-1602

Elsevier

Access to resources Recommend Favorite

Interference assessment of yellow fever vaccine with the immune response to a single-dose inactivated hepatitis A vaccine (1440 EL.U.). A controlled study in adults

By Gil A.   Gonzalez A.   Dal-Re R.   Calero J.R.  

Vaccine, Vol. 14, Iss. 11, 1996-08 ,pp. : 1028-1030

Elsevier

Access to resources Recommend Favorite

Predictors of Influenza Vaccine Acceptance among Healthy Adults

By Chapman G.B.   Coups E.J.  

Preventive Medicine, Vol. 29, Iss. 4, 1999-10 ,pp. : 249-262

Academic Press

Access to resources Recommend Favorite

Concurrent administration of inactivated hepatitis A vaccine with immune globulin in healthy adults

By Walter E.B.   Hornick R.B.   Poland G.A.   Richard Tucker   Bland C.L.   Clements D.A.   Rhamstine C.C.   Jacobson R.M.   Brown L.   Gress J.O.   Harris K.E.   Wiens B.L.   Nalin D.R.  

Vaccine, Vol. 17, Iss. 11, 1999-03 ,pp. : 1468-1473

Elsevier

Access to resources Recommend Favorite